&nbsp;

Metis-Depistage-cancer-du-poumon.pdf

New

Jun 2025

Drug

riTUXimab

Other Name(s): Rituxan® , Truxima™ , Riximyo™ , Ruxience™ , Riabni™

Quick Link(s): Drug Monograph, Patient Info Sheet

Updated

Jun 2025

Drug

riTUXimab (subcut)

Other Name(s): Rituxan® SC

Quick Link(s): Drug Monograph, Patient Info Sheet

Updated

Jun 2025

Regimen

RITU

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) - Single Agent - Indolent Lymphoma

Drugs Used:

riTUXimab

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

RITU(MNT)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma

Drugs Used:

riTUXimab

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Regimen

RITU(MNT-SC)

Cancer Type:

Hematologic,

Lymphoma - Non-Hodgkin's Low Grade

Intent: Palliative

Funding:

New Drug Funding Program

Rituximab (Biosimilar IV) and Rituximab SC - Maintenance Treatment - Lymphoma

Drugs Used:

riTUXimab (subcut)

Quick Link(s):

Regimen Monograph

Updated

Jun 2025

Document

Making-Decisions-About-Your-Care.pdf

New

Jun 2025

Document

RadiologyQualityAssuranceProgramManual.pdf

Jan 2019

Document

Making-Decisions-About-Your-Care-thumbnail.jpg

New

Jun 2025

Ressources sur le dépistage du cancer destinées aux Premières Nations, aux Inuits, aux Métis et aux Autochtones en milieu urbain

Drug

midostaurin

Other Name(s): Rydapt®

Quick Link(s): Drug Monograph, Patient Info Sheet

Updated

Jun 2025

Regimen

MIDO

Cancer Type:

Hematologic,

Rare Diseases

Intent: Palliative

Drugs Used:

midostaurin (Unfunded)